 |
SYDNEY, Aug. 7, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that the United States Food and Drug Administration (FDA) has awarded Rare Pediatric Disease Designation (RPDD) to Kazia's paxalisib (formerly GDC-0084) for the treatment of...
Seasonal gardening gives Killara businesses the chance to have beautiful outside areas all year round. Landscaping strategies are changed during the different seasons to help plants grow well in cha...
Daily Bulletin
A site survey (or land survey) is an essential early step in establishing the requirements for the successful execution and planning of construction and land development. It is a large-scale process...
Daily Bulletin
Whether you’re brewing a refreshing pale ale or perfecting your cider, every step shapes the final product. That’s where brite storage tanks truly shine. Crafting beverages Australians love takes mor...
Daily Bulletin
